Detection by enzymatic amplification of bcr-abl mRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia
- PMID: 2496773
Detection by enzymatic amplification of bcr-abl mRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia
Abstract
The Philadelphia chromosome of chronic myelogenous leukemia (CML) patients is caused by a translocation of the c-abl gene from chromosome 9 to the breakpoint cluster region (bcr) on chromosome 22. A new bcr-abl mRNA is expressed in these cases. We have developed a modified polymerase chain reaction (PCR) for the detection of this mRNA. The method is extremely sensitive, reliable, and relatively fast. The analysis of peripheral blood or bone marrow cells from CML patients treated with chemotherapy shows that the two possible mRNAs are expressed in various combinations. Our results show that even after myeloablative therapy for bone marrow transplantation bcr-abl mRNAs are still expressed. Further studies, however, are necessary to determine the clinical relevance of a small number of persisting cells expressing the bcr-abl mRNA.
Similar articles
-
Comparison of genomic DNA and cDNA for detection of residual disease after treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation.Blood. 1996 Mar 15;87(6):2588-93. Blood. 1996. PMID: 8630427
-
Detection of bcr/c-abl mRNA in chronic myelogenous leukemia by polymerase chain reaction to identify chromosome translocation.J Formos Med Assoc. 1992 Mar;91(3):247-51. J Formos Med Assoc. 1992. PMID: 1354683
-
Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.Blood. 1991 Nov 15;78(10):2759-67. Blood. 1991. PMID: 1824268
-
Chronic myelogenous leukemia: molecular and cellular aspects.J Cancer Res Clin Oncol. 1998;124(12):643-60. doi: 10.1007/s004320050228. J Cancer Res Clin Oncol. 1998. PMID: 9879825 Review.
-
[Genetic diagnosis of chronic myeloid leukemia].Nihon Rinsho. 2001 Dec;59(12):2336-41. Nihon Rinsho. 2001. PMID: 11766335 Review. Japanese.
Cited by
-
Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation.Ann Hematol. 1991 Oct;63(4):189-94. doi: 10.1007/BF01703441. Ann Hematol. 1991. PMID: 1932296
-
Usefulness of lymphokine-activated killer cells generated from bone marrow mononuclear cells for the purging of residual tumor cells in peripheral blood stem cell graft.Jpn J Cancer Res. 1996 Feb;87(2):161-9. doi: 10.1111/j.1349-7006.1996.tb03154.x. Jpn J Cancer Res. 1996. PMID: 8609065 Free PMC article.
-
Rearrangements of the tal-1 locus as clonal markers for T cell acute lymphoblastic leukemia.J Clin Invest. 1991 Jun;87(6):2029-35. doi: 10.1172/JCI115232. J Clin Invest. 1991. PMID: 2040693 Free PMC article.
-
Molecular biology in medicine.Postgrad Med J. 1992 Apr;68(798):251-62. doi: 10.1136/pgmj.68.798.251. Postgrad Med J. 1992. PMID: 1409188 Free PMC article. Review. No abstract available.
-
Detection of Philadelphia chromosome-positive cells from glass slide smears using the polymerase chain reaction.Am J Pathol. 1990 Jul;137(1):1-6. Am J Pathol. 1990. PMID: 2196814 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous